- Home
- DJTWW vs HAE Comparison
DJTWW vs HAE Comparison
Compare DJTWW & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DJTWW
- HAE
- Stock Information
- Founded
- DJTWW N/A
- HAE 1971
- Country
- DJTWW United States
- HAE United States
- Employees
- DJTWW N/A
- HAE N/A
- Industry
- DJTWW Computer Software: Programming Data Processing
- HAE Medical/Dental Instruments
- Sector
- DJTWW Technology
- HAE Health Care
- Exchange
- DJTWW Nasdaq
- HAE Nasdaq
- Market Cap
- DJTWW 4.2B
- HAE 3.8B
- IPO Year
- DJTWW 2021
- HAE 1991
- Fundamental
- Price
- DJTWW $20.33
- HAE $89.23
- Analyst Decision
- DJTWW
- HAE Strong Buy
- Analyst Count
- DJTWW 0
- HAE 8
- Target Price
- DJTWW N/A
- HAE $107.88
- AVG Volume (30 Days)
- DJTWW N/A
- HAE 726.9K
- Earning Date
- DJTWW N/A
- HAE 11-07-2024
- Dividend Yield
- DJTWW N/A
- HAE N/A
- EPS Growth
- DJTWW N/A
- HAE N/A
- EPS
- DJTWW N/A
- HAE 2.41
- Revenue
- DJTWW N/A
- HAE $1,361,223,000.00
- Revenue This Year
- DJTWW N/A
- HAE $7.71
- Revenue Next Year
- DJTWW N/A
- HAE $4.89
- P/E Ratio
- DJTWW N/A
- HAE $37.02
- Revenue Growth
- DJTWW N/A
- HAE 9.84
- 52 Week Low
- DJTWW N/A
- HAE $70.25
- 52 Week High
- DJTWW N/A
- HAE $97.97
- Technical
- Relative Strength Index (RSI)
- DJTWW N/A
- HAE 67.99
- Support Level
- DJTWW N/A
- HAE $70.25
- Resistance Level
- DJTWW N/A
- HAE $94.99
- Average True Range (ATR)
- DJTWW 0.00
- HAE 2.67
- MACD
- DJTWW 0.00
- HAE 1.67
- Stochastic Oscillator
- DJTWW 0.00
- HAE 76.72
About DJTWW Trump Media & Technology Group Corp.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest global conversation without discriminating against political ideology.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.